TOI

Oncology Institute Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↑ 6/10
  • Momentum↑ 6/10
Oncology Institute sales and earnings growth
TOI Growth
Good
  • Revenue Y/Y↑ 21.67%
  • EPS Y/Y↑ 21.91%
  • FCF Y/Y↑ 26.61%
Oncology Institute gross and profit margin trends
TOI Profitability
Neutral
  • Gross margin ↑ 14.80%
  • EPS margin↓ -13.10%
  • ROIC↓ -32.30%
Oncology Institute net debt vs free cash flow
TOI Risk
Great
  • Debt / Equity↓ -8.4
  • Debt / FCF↓ 2.8
  • Interest coverage↓ -4.8

Oncology Institute stock volatility is higher than the overall market. We give it a Great risk rating.

More Medical Care Facilities stocks ↗